PLATINUM INVESTMENT MANAGEMENT LTD
Position in RCUS — Arcus Biosciences, Inc.
CIK 1256071
SYDNEY AUSTRALIA 2000, C3
Position in RCUS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,899,087
-$299,304 QoQ
Shares Held
134,217
0.0% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PLATINUM INVESTMENT MANAGEMENT LTD holds $70,718,725 across 29 Biotechnology names. RCUS ranks #11 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
110,734 | $5,837,896 | |
| 2 | CNTA |
Centessa Pharmaceuticals plc
|
137,741 | $5,471,072 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
58,314 | $4,908,289 | |
| 4 | VERA |
Vera Therapeutics, Inc.
|
113,687 | $4,573,628 | |
| 5 | IMVT |
Immunovant, Inc.
|
181,774 | $4,515,266 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
112,066 | $4,313,420 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
64,752 | $4,059,950 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
49,269 | $3,658,715 |
All Filings in RCUS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,899,087 | 134,217 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,198,391 | 134,217 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,091,448 | 153,783 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,251,793 | 153,783 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $1,207,196 | 153,783 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,289,828 | 153,783 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,351,342 | 153,783 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,342,115 | 153,783 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,859,034 | 204,398 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,904,001 | 204,398 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,668,944 | 204,398 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $4,724,349 | 232,612 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,242,842 | 232,612 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,202,318 | 154,851 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,616,164 | 61,780 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,565,505 | 61,780 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,949,776 | 61,780 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,500,236 | 61,780 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,154,268 | 61,780 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,067,463 | 75,290 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $2,114,143 | 75,290 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,260,025 | 87,058 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,492,174 | 87,058 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,153,814 | 87,058 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,439,911 | 103,740 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||